Ƙarin Ozempic yana nufin mafi kyawun iko akan nau'in ciwon sukari na 2

A KYAUTA Kyauta 8 | eTurboNews | eTN
Avatar na Linda Hohnholz
Written by Linda Hohnholz

Novo Nordisk a yau ta sanar da cewa Hukumar Kula da Abinci da Magunguna ta Amurka (FDA) ta amince da allurar Ozempic® (semaglutide) na 2 MG, analog na glucagon-kamar peptide-1 (GLP-1) sau ɗaya kowane mako wanda aka nuna tare da abinci da motsa jiki. don inganta sukarin jini a cikin manya masu fama da ciwon sukari na 2 da kuma rage haɗarin manyan abubuwan da ke faruwa a cikin zuciya kamar bugun zuciya, bugun jini ko mutuwa a cikin manya masu fama da ciwon sukari na 2 da cututtukan zuciya da aka sani.2 Ozempic® ba magani bane na asarar nauyi, amma yana iya taimaka wa mutane su rasa wani nauyi. Ozempic® zai kasance a cikin allurai uku na warkewa (0.5 MG, 1 MG, da 2 MG) don taimakawa mutanen da ke da nau'in ciwon sukari na 2 su kai ga burin sukarin jininsu (A1C), yanzu gami da waɗanda ke da A1C mafi girma waɗanda suka kasa cimma burinsu. A1C manufa.

A cikin shirin gwaji na asibiti na Ozempic® SUSTAIN kashi 3, har zuwa 73% na mutanen da ke da nau'in ciwon sukari na 2 da aka yi wa magani tare da Ozempic® 1 MG sun rage sukarin jininsu kuma sun kai ga Ƙungiyar Ciwon sukari ta Amurka na <7%.3-5 Duk da haka, a can. har yanzu mutanen da ba su da maƙasudin sukari na jini.1,4-10 Ozempic® 2 MG yana taimaka wa waɗanda ke buƙatar ƙarin sarrafa glycemic kuma zaɓi ne mai mahimmanci ga marasa lafiya da masu samarwa a cikin ci gaba da jiyya na nau'in ciwon sukari na 2.

"Nau'in ciwon sukari na 2 wata cuta ce mai rikitarwa da za ta iya ci gaba a tsawon lokaci ko da mutum yana sarrafa shi da magani, abinci da motsa jiki," in ji Dokta Juan Pablo Frias, darektan likita na Velocity Clinical Research, Los Angeles da kuma babban mai bincike na SUSTAIN FORTE. gwajin asibiti na lokaci 3 wanda ke goyan bayan amincewar Ozempic® 2 MG. "Tare da ingantaccen aminci da ingancinsa, Ozempic® yana taimakawa wajen sarrafa glucose na jini kuma yana ba da babban haɗarin cututtukan zuciya da jijiyoyin jini a cikin manya masu fama da ciwon sukari na 2 da sanannun cututtukan zuciya, ƙari kuma yana iya taimakawa marasa lafiya da yawa su rasa nauyi. Tare da kashi na 2 MG, muna da ƙarin zaɓi don haka marasa lafiya za su iya kasancewa a kan jiyya iri ɗaya ko da sukarin jininsu yana buƙatar canzawa. "

A cikin gwajin SUSTAIN FORTE, mutanen da ke da matsakaicin farawa A1C na 8.9% da aka yi wa magani tare da Ozempic® 2 MG sun sami raguwar ƙididdiga da haɓakar sukarin jini na 2.1% a mako na 40 idan aka kwatanta da 1.9% tare da Ozempic® 1 mg (P<0.01) .1 A cikin wannan binciken, mutanen da ke da matsakaicin nauyin farawa na 219 lb da aka bi da su tare da Ozempic® 2 MG sun sami asarar nauyi na 14.1 lb idan aka kwatanta da asarar nauyi na 12.5 lb tare da Ozempic® 1 MG; bambancin bai kasance mai mahimmanci a kididdiga ba. Domin duka allurai biyu na Ozempic®, ba a sami sabbin siginonin aminci da aka gano.1 Mafi yawan abubuwan da suka fi dacewa sune gastrointestinal fili. ).1

"Ozempic® yana kan jagorancin taimakawa Novo Nordisk don kawo canji a cikin kula da ciwon sukari, tare da fiye da mutane miliyan daya masu fama da ciwon sukari na 2 a Amurka sun yi amfani da Ozempic®," in ji Doug Langa, mataimakin shugaban zartarwa, ayyukan Arewacin Amirka da kuma shugaban kasa. na Novo Nordisk Inc. "Tare da Ozempic® yanzu yana samuwa a cikin nau'o'in ƙarfin allurai iri-iri, muna da kyakkyawan fata za mu iya taimaka wa mutane da yawa masu fama da ciwon sukari na 2 waɗanda ke buƙatar ƙarin sarrafa sukarin jini don sanin amfanin Ozempic®."  

Novo Nordisk yana tsammanin ƙaddamar da Ozempic® 2 MG a cikin Amurka ba da daɗewa ba. Swiss Medic ta amince da Ozempic® 2 MG a cikin Satumba 2021 sannan Health Canada da Hukumar Kula da Magunguna ta Turai a cikin Janairu 2022.

Game da marubucin

Avatar na Linda Hohnholz

Linda Hohnholz

Edita a shugaba don eTurboNews bisa ga eTN HQ.

Labarai
Sanarwa na
bako
0 comments
Bayanin Cikin Lissafi
Duba duk maganganu
0
Za a son tunanin ku, don Allah sharhi.x
()
x
Share zuwa...